HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$32.46
Day range
$31.58 - $32.56
Year range
$21.16 - $46.48
Market cap
5.10B USD
Avg Volume
2.70M
P/E ratio
85.94
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 141.15M | 92.13% |
Operating expense | 87.37M | 55.05% |
Net income | 28.19M | 309.75% |
Net profit margin | 19.97 | 113.35% |
Earnings per share | 0.17 | 325.00% |
EBITDA | 34.86M | 294.52% |
Effective tax rate | 8.84% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 251.87M | 15.93% |
Total assets | 702.61M | 75.12% |
Total liabilities | 426.18M | 90.57% |
Total equity | 276.43M | — |
Shares outstanding | 145.90M | — |
Price to book | 17.08 | — |
Return on assets | 12.82% | — |
Return on capital | 17.03% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 28.19M | 309.75% |
Cash from operations | 7.44M | 34.32% |
Cash from investing | -3.99M | -326.18% |
Cash from financing | -6.44M | -4,872.59% |
Net change in cash | -3.00M | -140.33% |
Free cash flow | 2.21M | 98.44% |
About
Founded
1993
Headquarters
Website
Employees
370
